Sign up to save your podcasts
Or
Share Gordon Van Slyke: A Trial Participant’s Inside Look at New Alzheimer’s Drug Leqembi
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Gordon Van Slyke: A Trial Participant’s Inside Look at New Alzheimer’s Drug Leqembi
When Gordon Van Slyke, 75, decided to participate in the phase drug trials for Eisai and Biogen’s new monoclonal antibody drug Leqembi (lecanemab), it was his family history with Alzheimer’s that motivated him.
Read more about his story:
https://www.beingpatient.com/lecanemab-leqembi-trial-participant-story/
View all episodes
By Being Patient
4.6
99 ratings
When Gordon Van Slyke, 75, decided to participate in the phase drug trials for Eisai and Biogen’s new monoclonal antibody drug Leqembi (lecanemab), it was his family history with Alzheimer’s that motivated him.
Read more about his story:
https://www.beingpatient.com/lecanemab-leqembi-trial-participant-story/
More shows like Brain Talk | Being Patient for Alzheimer's Patients and Caregivers
View all
TED Radio Hour
22,074 Listeners
The Daily
111,917 Listeners
Up First from NPR
56,231 Listeners
Dhru Purohit Show
3,529 Listeners
12 Step Guide To Caregiving/Alzheimers and Dementia
37 Listeners
The Forgetting: Inside the Mind of Alzheimer's
66 Listeners
Fiction - Comedy Fiction
6,447 Listeners
Huberman Lab
28,473 Listeners
The Ezra Klein Show
15,321 Listeners
The Mel Robbins Podcast
20,562 Listeners
Truth, Lies & Alzheimer's
15 Listeners
The Jefferson Fisher Podcast
8,054 Listeners
The Headlines
492 Listeners
The Oprah Podcast
1,392 Listeners
Good Hang with Amy Poehler
7,419 Listeners